A detailed history of Richwood Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Richwood Investment Advisors, LLC holds 18,111 shares of PFE stock, worth $475,232. This represents 0.43% of its overall portfolio holdings.

Number of Shares
18,111
Previous 18,161 0.28%
Holding current value
$475,232
Previous $508,000 3.15%
% of portfolio
0.43%
Previous 0.45%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$27.7 - $31.39 $1,385 - $1,569
-50 Reduced 0.28%
18,111 $524,000
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $2,046 - $2,397
81 Added 0.45%
18,161 $508,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $52,582 - $60,381
-2,031 Reduced 10.1%
18,080 $501,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $5,696 - $7,398
-218 Reduced 1.07%
20,111 $578,000
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $47,076 - $55,027
-1,467 Reduced 6.73%
20,329 $674,000
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $31,207 - $36,106
-864 Reduced 3.81%
21,796 $799,000
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $39,429 - $51,331
-1,001 Reduced 4.23%
22,660 $924,000
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $15,906 - $20,764
-381 Reduced 1.58%
23,661 $1.21 Million
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $19,910 - $24,306
-455 Reduced 1.86%
24,042 $1.05 Million
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $26,987 - $31,998
-580 Reduced 2.31%
24,497 $1.28 Million
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $73,977 - $91,667
1,617 Added 6.89%
25,077 $1.3 Million
Q4 2021

Feb 17, 2022

BUY
$41.32 - $61.25 $969,367 - $1.44 Million
23,460 New
23,460 $1.39 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Richwood Investment Advisors, LLC Portfolio

Follow Richwood Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richwood Investment Advisors, LLC with notifications on news.